| Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology DG Pfister, S Spencer, D Adelstein, D Adkins, Y Anzai, DM Brizel, ... Journal of the National Comprehensive Cancer Network 18 (7), 873-898, 2020 | 786 | 2020 |
| NCCN guidelines insights: head and neck cancers, version 1.2018 AD Colevas, SS Yom, DG Pfister, S Spencer, D Adelstein, D Adkins, ... Journal of the National Comprehensive Cancer Network 16 (5), 479-490, 2018 | 556 | 2018 |
| Head and neck cancers, version 2.2014 DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ... Journal of the National Comprehensive Cancer Network 12 (10), 1454-1487, 2014 | 531 | 2014 |
| Head and neck cancers, version 1.2015 DG Pfister, S Spencer, DM Brizel, B Burtness, PM Busse, JJ Caudell, ... Journal of the National Comprehensive Cancer Network 13 (7), 847-856, 2015 | 431 | 2015 |
| A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study JG Scott, A Berglund, MJ Schell, I Mihaylov, WJ Fulp, B Yue, E Welsh, ... The lancet oncology 18 (2), 202-211, 2017 | 424 | 2017 |
| NCCN guidelines insights: head and neck cancers, version 2.2017 D Adelstein, ML Gillison, DG Pfister, S Spencer, D Adkins, DM Brizel, ... Journal of the National Comprehensive Cancer Network 15 (6), 761-770, 2017 | 341 | 2017 |
| Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer JJ Caudell, PE Schaner, RF Meredith, JL Locher, LM Nabell, WR Carroll, ... International Journal of Radiation Oncology* Biology* Physics 73 (2), 410-415, 2009 | 337 | 2009 |
| Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy KA Ahmed, DG Stallworth, Y Kim, PAS Johnstone, LB Harrison, ... Annals of Oncology 27 (3), 434-441, 2016 | 255 | 2016 |
| Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002) SS Yom, P Torres-Saavedra, JJ Caudell, JN Waldron, ML Gillison, P Xia, ... Journal of Clinical Oncology 39 (9), 956, 2021 | 240 | 2021 |
| Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck JJ Caudell, PE Schaner, RA Desmond, RF Meredith, SA Spencer, ... International Journal of Radiation Oncology* Biology* Physics 76 (2), 403-409, 2010 | 238 | 2010 |
| Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement DJ Thomson, D Palma, M Guckenberger, P Balermpas, JJ Beitler, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 618-627, 2020 | 228 | 2020 |
| NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines JJ Caudell, ML Gillison, E Maghami, S Spencer, DG Pfister, D Adkins, ... Journal of the National Comprehensive Cancer Network 20 (3), 224-234, 2022 | 222 | 2022 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 221 | 2021 |
| Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with … H Zhang, CM Graham, O Elci, ME Griswold, X Zhang, MA Khan, K Pitman, ... Radiology 269 (3), 801-809, 2013 | 210 | 2013 |
| Management of salivary gland malignancy: ASCO guideline JL Geiger, N Ismaila, B Beadle, JJ Caudell, N Chau, D Deschler, ... Journal of Clinical Oncology 39 (17), 1909-1941, 2021 | 202 | 2021 |
| Radiotherapy in the management of giant cell tumor of bone JJ Caudell, MT Ballo, GK Zagars, VO Lewis, KL Weber, PP Lin, RA Marco, ... International Journal of Radiation Oncology* Biology* Physics 57 (1), 158-165, 2003 | 197 | 2003 |
| The future of personalised radiotherapy for head and neck cancer JJ Caudell, JF Torres-Roca, RJ Gillies, H Enderling, S Kim, A Rishi, ... The Lancet Oncology 18 (5), e266-e273, 2017 | 188 | 2017 |
| The 2019 mathematical oncology roadmap RC Rockne, A Hawkins-Daarud, KR Swanson, JP Sluka, JA Glazier, ... Physical biology 16 (4), 041005, 2019 | 169 | 2019 |
| Radiosensitivity differences between liver metastases based on primary histology suggest implications for clinical outcomes after stereotactic body radiation therapy KA Ahmed, JJ Caudell, G El-Haddad, AE Berglund, EA Welsh, B Yue, ... International Journal of Radiation Oncology* Biology* Physics 95 (5), 1399-1404, 2016 | 151 | 2016 |
| Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or … KA Ahmed, YA Abuodeh, MI Echevarria, JA Arrington, DG Stallworth, ... Annals of Oncology 27 (12), 2288-2294, 2016 | 138 | 2016 |
Eduardo MorosMoffitt Cancer CenterAdresse e-mail validée de moffitt.org
